Paragon Pharmaceuticals is an innovative global development and biopharmaceutical investment firm that establishes, fosters, and manages life science companies.
From 2000-2009, Jeff was President and Chief Executive Officer of Ovation Pharmaceuticals, Inc.—a biopharmaceutical company he founded in 2000. Under his leadership, Ovation Pharmaceuticals was named 2006 Scrip Pharmaceutical “Company of the Year” for companies with revenues up to $5 billion.
In March 2009, Ovation Pharmaceuticals was acquired by Lundbeck, Inc., and Jeff served as President and Chief Executive Officer of the company for the following year. Prior to founding Ovation Pharmaceuticals, Jeff led MedCare HealthCare, a publicly-held healthcare company where he served as Chairman and CEO.
Jeff serves on several business and civic boards including Discover Financial Services, the University of Chicago Medical Center, the Museum of Science and Industry, the Chicagoland Entrepreneurial Center and the Young Presidents Organization. He is also a member of the Commerce Club and the Economic Club.
Jeff received his B.S. from Northern Illinois University and earned his M.B.A. from DePaul University. He is a member of the 2010 class of Henry Crown Fellows at the Aspen Institute.more » « less